Twist Bioscience

Update in progress

TWST (NasdaqGS)

Company RatingNeutral
SectorHealthcare
IndustryBiotechnology

Twist Bioscience manufactures and sells synthetic DNA products for therapeutics, diagnostics, chemicals, food/agriculture, data storage, and academic research. Its offerings include synthetic genes, gene fragments, and oligo pools for targeted sequencing, CRISPR experiments, DNA origami, and data storage; NGS tools, methylation and RNA sequencing workflows; viral controls and diagnostic panels; and antibody engineering solutions. HQ in South San Francisco; founded 2013; collaborates with BitBiome.

Company score

Sentiment: -0.29; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.00; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: 0.15; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: -0.56; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: -0.07; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: -0.18; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive